| Application no. and date | 19831677.0 (espacenet) (Federated) (European Patent Register), 20191218 | | Patent/reg. no. and date | DK/EP 3890740, 20230301 | | Publication date | 20211013 | | Priority no. and date | GB 201820582, 20181218, GB 201911007, 20190801, GB 201917701, 20191204 | | EP pub. no. and date |
EP 3890740 20211013 | | Effective date | | | Applicant/owner | University of Bern, Verwaltungsdirektion
Hochschulstrasse 6
3012 Bern, CH,
Argenx BVBA, Industriepark Zwijnaarde 7
9052 Gent, BE | | Applicant ref. no. | 6.2303.003 | | Inventor | DE HAARD, Hans, c/o ARGENX BVBA Industriepark Zwijnaarde 7
9052 Gent, BE,
FUNG, Samson, c/o ARGENX BVBA Industriepark Zwijnaarde 7
9052 Gent, BE,
LEUPIN, Nicolas, c/o ARGENX BVBA Industriepark Zwijnaarde 7
9052 Gent, BE,
VAN ROMPAEY, Luc, c/o ARGENX BVBA Industriepark Zwijnaarde 7
9052 Gent, BE,
OCHSENBEIN, Adrian, c/o University of Bern Verwaltungsdirektion
Hochschulstrasse 6
3012 Bern, CH,
RIETHER, Carsten, c/o University of Bern Verwaltungsdirektion
Hochschulstrasse 6
3012 Bern, CH | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) , C07K 16/28 (2006.01) | | Title | CD70 og venetoclax, en BCL-2 inhibitor, kombinationsterapi til behandling af akut myeloid leukæmi | | Int. application no. | EP2019085982 | | Int. publication no. | WO2020127503 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
